These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22172471)

  • 1. Chapter III: Management of cardiovascular risk factors and medical therapy.
    Diehm N; Schmidli J; Setacci C; Ricco JB; de Donato G; Becker F; Robert-Ebadi H; Cao P; Eckstein HH; De Rango P; Teraa M; Moll FL; Dick F; Davies AH; Lepäntalo M; Apelqvist J
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S33-42. PubMed ID: 22172471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter IV: Treatment of critical limb ischaemia.
    Setacci C; de Donato G; Teraa M; Moll FL; Ricco JB; Becker F; Robert-Ebadi H; Cao P; Eckstein HH; De Rango P; Diehm N; Schmidli J; Dick F; Davies AH; Lepäntalo M; Apelqvist J
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S43-59. PubMed ID: 22172473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of critical limb ischaemia: where do we stand today?
    Lambert MA; Belch JJ
    J Intern Med; 2013 Oct; 274(4):295-307. PubMed ID: 23795817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter VI: Follow-up after revascularisation.
    Dick F; Ricco JB; Davies AH; Cao P; Setacci C; de Donato G; Becker F; Robert-Ebadi H; Eckstein HH; De Rango P; Diehm N; Schmidli J; Teraa M; Moll FL; Lepäntalo M; Apelqvist J
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S75-90. PubMed ID: 22172475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chapter I: Definitions, epidemiology, clinical presentation and prognosis.
    Becker F; Robert-Ebadi H; Ricco JB; Setacci C; Cao P; de Donato G; Eckstein HH; De Rango P; Diehm N; Schmidli J; Teraa M; Moll FL; Dick F; Davies AH; Lepäntalo M; Apelqvist J
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S4-12. PubMed ID: 22172472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical limb ischaemia.
    Minar E
    Hamostaseologie; 2009 Jan; 29(1):102-9. PubMed ID: 19151858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing risk factors for atherosclerosis in critical limb ischaemia.
    Gottsäter A
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):478-83. PubMed ID: 16631394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal.
    Lawall H; Bramlage P; Amann B
    Thromb Haemost; 2010 Apr; 103(4):696-709. PubMed ID: 20174766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Office management of peripheral arterial disease.
    Aronow WS
    Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights on the role of diabetes and geographic variation in patients with critical limb ischaemia.
    Van Belle E; Nikol S; Norgren L; Baumgartner I; Driver V; Hiatt WR; Belch J
    Eur J Vasc Endovasc Surg; 2011 Sep; 42(3):365-73. PubMed ID: 21696982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention of coronary artery disease.
    Hall SL; Lorenc T
    Am Fam Physician; 2010 Feb; 81(3):289-96. PubMed ID: 20112887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral arterial disease in women.
    Aronow WS
    Maturitas; 2009 Dec; 64(4):204-11. PubMed ID: 19853389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chapter II: Diagnostic methods.
    Cao P; Eckstein HH; De Rango P; Setacci C; Ricco JB; de Donato G; Becker F; Robert-Ebadi H; Diehm N; Schmidli J; Teraa M; Moll FL; Dick F; Davies AH; Lepäntalo M; Apelqvist J
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S13-32. PubMed ID: 22172470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary and optimal medical management of peripheral arterial disease.
    Tattersall MC; Johnson HM; Mason PJ
    Surg Clin North Am; 2013 Aug; 93(4):761-78, vii. PubMed ID: 23885930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.